352 related articles for article (PubMed ID: 25445206)
1. Interferon regulatory factors: critical mediators of human lupus.
Jensen MA; Niewold TB
Transl Res; 2015 Feb; 165(2):283-95. PubMed ID: 25445206
[TBL] [Abstract][Full Text] [Related]
2. Interferon regulatory factors in human lupus pathogenesis.
Salloum R; Niewold TB
Transl Res; 2011 Jun; 157(6):326-31. PubMed ID: 21575916
[TBL] [Abstract][Full Text] [Related]
3. A compass that points to lupus: genetic studies on type I interferon pathway.
Kyogoku C; Tsuchiya N
Genes Immun; 2007 Sep; 8(6):445-55. PubMed ID: 17581625
[TBL] [Abstract][Full Text] [Related]
4. Interferon regulatory factor 5 in the pathogenesis of systemic lupus erythematosus.
Cham CM; Ko K; Niewold TB
Clin Dev Immunol; 2012; 2012():780436. PubMed ID: 23251221
[TBL] [Abstract][Full Text] [Related]
5. Murine dendritic cell type I IFN production induced by human IgG-RNA immune complexes is IFN regulatory factor (IRF)5 and IRF7 dependent and is required for IL-6 production.
Yasuda K; Richez C; Maciaszek JW; Agrawal N; Akira S; Marshak-Rothstein A; Rifkin IR
J Immunol; 2007 Jun; 178(11):6876-85. PubMed ID: 17513736
[TBL] [Abstract][Full Text] [Related]
6. [Interleukin-2 signaling pathway regulating molecules in systemic lupus erythematosus].
Guo Q; Chen XY; Su Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1100-1104. PubMed ID: 27987522
[TBL] [Abstract][Full Text] [Related]
7. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
Tada Y; Kondo S; Aoki S; Koarada S; Inoue H; Suematsu R; Ohta A; Mak TW; Nagasawa K
Arthritis Rheum; 2011 Mar; 63(3):738-48. PubMed ID: 21305501
[TBL] [Abstract][Full Text] [Related]
8. New insights into the immunopathogenesis of systemic lupus erythematosus.
Tsokos GC; Lo MS; Costa Reis P; Sullivan KE
Nat Rev Rheumatol; 2016 Nov; 12(12):716-730. PubMed ID: 27872476
[TBL] [Abstract][Full Text] [Related]
9. Interferon regulatory factors: beyond the antiviral response and their link to the development of autoimmune pathology.
Santana-de Anda K; Gómez-Martín D; Díaz-Zamudio M; Alcocer-Varela J
Autoimmun Rev; 2011 Dec; 11(2):98-103. PubMed ID: 21872684
[TBL] [Abstract][Full Text] [Related]
10. Linking interferon regulatory factors to the pathogenesis of human lupus.
Patel DR
Transl Res; 2011 Jun; 157(6):323-5. PubMed ID: 21575915
[No Abstract] [Full Text] [Related]
11. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors.
Honda K; Taniguchi T
Nat Rev Immunol; 2006 Sep; 6(9):644-58. PubMed ID: 16932750
[TBL] [Abstract][Full Text] [Related]
12. Systemic lupus erythematosus: all roads lead to type I interferons.
Pascual V; Farkas L; Banchereau J
Curr Opin Immunol; 2006 Dec; 18(6):676-82. PubMed ID: 17011763
[TBL] [Abstract][Full Text] [Related]
13. Systematic identification of novel SLE related autoantibodies responsible for type I IFN production in human plasmacytoid dendritic cells.
Kassim SH; Jordan J; Schreiter J; Adhikarakunnathu S; Baribaud F; San Mateo L
Cell Immunol; 2013; 284(1-2):119-28. PubMed ID: 23973875
[TBL] [Abstract][Full Text] [Related]
14. Interferon alpha as a primary pathogenic factor in human lupus.
Niewold TB
J Interferon Cytokine Res; 2011 Dec; 31(12):887-92. PubMed ID: 21923413
[TBL] [Abstract][Full Text] [Related]
15. The role of toll-like receptors in systemic lupus erythematosus.
Rahman AH; Eisenberg RA
Springer Semin Immunopathol; 2006 Oct; 28(2):131-43. PubMed ID: 17047954
[TBL] [Abstract][Full Text] [Related]
16. Lupus-Associated Immune Complexes Activate Human Neutrophils in an FcγRIIA-Dependent but TLR-Independent Response.
Bonegio RG; Lin JD; Beaudette-Zlatanova B; York MR; Menn-Josephy H; Yasuda K
J Immunol; 2019 Feb; 202(3):675-683. PubMed ID: 30610165
[TBL] [Abstract][Full Text] [Related]
17. Genetic variation near IRF8 is associated with serologic and cytokine profiles in systemic lupus erythematosus and multiple sclerosis.
Chrabot BS; Kariuki SN; Zervou MI; Feng X; Arrington J; Jolly M; Boumpas DT; Reder AT; Goulielmos GN; Niewold TB
Genes Immun; 2013 Dec; 14(8):471-8. PubMed ID: 23965942
[TBL] [Abstract][Full Text] [Related]
18. Immunogenetics of systemic lupus erythematosus: A comprehensive review.
Ghodke-Puranik Y; Niewold TB
J Autoimmun; 2015 Nov; 64():125-36. PubMed ID: 26324017
[TBL] [Abstract][Full Text] [Related]
19. Dysfunction of TRIM21 in interferon signature of systemic lupus erythematosus.
Kamiyama R; Yoshimi R; Takeno M; Iribe Y; Tsukahara T; Kishimoto D; Kunishita Y; Sugiyama Y; Tsuchida N; Nakano H; Minegishi K; Tamura M; Asami Y; Kirino Y; Ishigatsubo Y; Ozato K; Nakajima H
Mod Rheumatol; 2018 Nov; 28(6):993-1003. PubMed ID: 29385873
[TBL] [Abstract][Full Text] [Related]
20. Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts.
Raschi E; Chighizola CB; Cesana L; Privitera D; Ingegnoli F; Mastaglio C; Meroni PL; Borghi MO
Arthritis Res Ther; 2018 Aug; 20(1):187. PubMed ID: 30157947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]